A year after specialist doctors were allowed to prescribe cannabis-based medicines, NICE changed its guidelines to allow two of them, for two forms of epilepsy and for multiple sclerosis. It did not allow them for other conditions such as chronic pain, which some patients' groups called a missed opportunity.[1]
Listed for context. No score change is recorded for United Kingdom here.
References
- Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis in the UK, 1973–2004Suzanne Taylor · In Cannabis: Global Histories, edited by Lucas Richert, James H. Mills · MIT Press · 2021 · pp. 357 · ISBN 9780262366137
Checked. The date and the event were compared with a source that was read.